With the rising demand for weight-loss medications, compounding pharmacies have been making headlines lately. On October 30, the FDA announced that all doses of Novo Nordisk’s Ozempic and Wegovy ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients. U.S. regulators are trying to shut down the ...
The company projects initial revenue generation from its Sildenafil Cream formulation in Q4 2025, backed by its 503B compounding strategy. Daré plans to provide updates in Q2 2025 on strategic ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
When Chris Spears' pharmacy didn't have the obesity drug his doctor prescribed in 2023, he found another option while scrolling on Facebook. His feed was full of advertisements for alternatives to the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results